May 13, 2021: Disparities in U=U awareness; sexual satisfaction trends among PLWH; PrEP use among cis women; HCV epidemiology in trans women.
May 6, 2021: Epigenetic aging and HIV treatment initiation; effects of ART on cognitive decline; dearth of osteoporosis screenings for PLWH; physical therapy vs. opioids for bone/muscle pain.
Studies show increasing access to screening can go a long way in reaching people at higher risk for HCV.
“This Information Will Be Useful in the Future”: How a Tuberculosis Toolkit Became a COVID-19 Timeline
A newly launched chronology traces the unfolding pandemic and the consequences of economic and political decisions around the world.
A study suggests olfactory function may be a useful tool in distinguishing between HAND and a precursor for Alzheimer’s disease in older people living with HIV.
April 22, 2021: Weight gain and CVD risk after treatment initiation; stroke type divergence among PLWH; exercise and CD4; a new approach to pain research in HIV.
April 15, 2021: Alcohol and neurocognitive impairment; using hair analysis to measure substance use; integrase inhibitors' impact on verbal learning; hepatocellular carcinoma trends among PLWH.
Here's a walkthrough of some of the most compelling stories coming out of the year's biggest HIV science meeting to date.
Helping my longtime friend Jeremy find such trials alerted me to this ongoing problem—which will only be reversed if patients, doctors, and trial reviewers keep pushing back on Pharma.
David Alain Wohl, M.D., on new findings from CROI 2021 that help us better understand the connections between sleep, diet, and quality of life among people living with HIV.